Association between baseline lactate dehydrogenase and immune-related adverse events among patients with melanoma varies by tumor stage at immune checkpoint inhibitor initiation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Academy of Dermatology 2023-12, Vol.89 (6), p.1264-1268
Hauptverfasser:	Pan, Catherina X., Lau, William C., Kim, Daniel Y., Lau, Charles B., Rowley, Rachael, Kanwar, Ruhi, LeBoeuf, Nicole R., Nambudiri, Vinod E.
Format:	Artikel
Sprache:	eng
Schlagworte:	CTLA-4 inhibitors hepatobiliary immune checkpoint inhibitors immune-related adverse events immunosuppression immunotherapy lactate dehydrogenase liver melanoma PD-1 inhibitors toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!